Siedlecki-Wullich et al demonstrated a statistically significant increase in serum miR-92a-3p in the patient group with Alzheimer's disease compared with the group with normal cognitive abilities and indicated an increasing trend in the incidence of this serum in the MCI group ( 26 ).
← all excerpts
Changes in cognitive ability and serum microRNA levels during aging in mice.
1
—
—